Avacta Group Plc
OTC: AVCTF0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Christina Marie Coughlin
- Employees
- 154
- Headquarters
- Wetherby, United Kingdom
- IPO year
- 2020
- Market cap
- $468.4M
- Website
- https://www.avacta.com
Loading AVCTF…
Loading profile data…Frequently asked questions about AVCTF
What does Avacta Group Plc (AVCTF) do?
Avacta Group Plc, a biopharmaceutical enterprise operating at the clinical stage, was established in 2003 and is headquartered in Wetherby, UK. The company specializes in the creation of cancer treatments and diagnostic solutions, leveraging its distinctive Affimer and pre|CISION proprietary platforms. Its operations span the United Kingdom, Nor...
Where does AVCTF trade?
Avacta Group Plc (AVCTF) trades on the Other OTC.
What sector is AVCTF in?
Avacta Group Plc (AVCTF) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Avacta Group Plc?
Christina Marie Coughlin is the chief executive officer of Avacta Group Plc (AVCTF).
Where is Avacta Group Plc headquartered?
Avacta Group Plc is headquartered in United Kingdom.
Does AVCTF pay a dividend?
Avacta Group Plc (AVCTF) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did AVCTF go public?
Avacta Group Plc (AVCTF) completed its initial public offering in 2020.